Aller au contenu principal
Profil bibliographique

Dikran R. Guisso

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

13Publications signalées
269Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Genetics and Neurodevelopmental DisordersGlycogen Storage Diseases and MyoclonusAutoimmune Neurological Disorders and TreatmentsAutism Spectrum Disorder ResearchProtein Tyrosine Phosphatases

Les publications récentes

Accès ouvert 2022 article OpenAlex

Laforin targets malin to glycogen in Lafora progressive myoclonus epilepsy

Sharmistha Mitra, Baozhi Chen, P. Wang, Erin E. Chown et autres

Glycogen is the largest cytosolic macromolecule and is kept in solution through a regular system of short branches allowing hydration. This structure was thought to solely require balanced glycogen synthase and branching enzyme activities. Deposition of overlong branched glycogen in the fatal …

us, ca (code pays fourni par la source)

17 citations Disease Models & Mechanisms
Accès ouvert 2022 article OpenAlex

AAV-Mediated Artificial miRNA Reduces Pathogenic Polyglucosan Bodies and Neuroinflammation in Adult Polyglucosan Body and Lafora Disease Mouse Models

Emrah Gumusgoz, Sahba Kasiri, Dikran R. Guisso, Jun Wu et autres

Adult polyglucosan body disease (APBD) and Lafora disease (LD) are autosomal recessive glycogen storage neurological disorders. APBD is caused by mutations in the glycogen branching enzyme (GBE1) gene and is characterized by progressive upper and lower motor neuron dysfunction and premature death. …

us (code pays fourni par la source)

34 citations Neurotherapeutics
Accès ouvert 2021 article OpenAlex

Gys1 antisense therapy rescues neuropathological bases of murine Lafora disease

Saija Ahonen, Silvia Nitschke, Tamar R. Grossman, Holly Kordasiewicz et autres

Lafora disease is a fatal progressive myoclonus epilepsy. At root, it is due to constant acquisition of branches that are too long in a subgroup of glycogen molecules, leading them to precipitate and accumulate into Lafora bodies, which drive a neuroinflammatory response …

ca, us (code pays fourni par la source)

53 citations Brain
Accès ouvert 2021 review OpenAlex

Rathke cleft cyst with size fluctuation: A systematic literature review and case illustration

Dikran R. Guisso, Ahmad Kareem Almekkawi, Tarek Y. El Ahmadieh, Julia Yi et autres

Rathke cleft cysts (RCCs) are known sellar/suprasellar lesions that can grow and become symptomatic. For most asymptomatic lesions, stability is a typical outcome of surveillance; however, random relapse or cyst size fluctuation may also be observed. The conventional treatment for growing cysts …

us, lb (code pays fourni par la source)

2 citations Interdisciplinary Neurosurgery
Accès ouvert 2021 preprint OpenAlex

Targeting Gys1 with AAV‐SaCas9 decreases pathogenic polyglucosan bodies and neuroinflammation in Adult Polyglucosan Body and Lafora disease mouse models

Emrah Gumusgoz, Dikran R. Guisso, Sahba Kasiri, Jun Wu et autres

Summary Many adult and most childhood neurological diseases have a genetic basis. CRISPR/Cas9 biotechnology holds great promise in neurological therapy, pending the clearance of major delivery, efficiency and specificity hurdles. We apply CRISPR/Cas9 genome editing in its simplest modality, namely inducing gene …

us (code pays fourni par la source)

2 citations bioRxiv (Cold Spring Harbor Laboratory)
Accès ouvert 2021 preprint OpenAlex

Gys1 antisense therapy rescues neuropathological bases of murine Lafora disease

Saija Ahonen, Silvia Nitschke, Tamar R. Grossman, Holly Kordasiewicz et autres

Abstract Lafora disease is a fatal progressive myoclonus epilepsy. At root, it is due to constant acquisition of branches that are too long in a subgroup of glycogen molecules, leading them to precipitate and accumulate into Lafora bodies, which drive a neuroinflammatory …

ca, us (code pays fourni par la source)

7 citations bioRxiv (Cold Spring Harbor Laboratory)
Accès ouvert 2020 article OpenAlex

An inducible glycogen synthase-1 knockout halts but does not reverse Lafora disease progression in mice

Silvia Nitschke, Erin E. Chown, Xiaochu Zhao, Shoghig Gabrielian et autres

Malstructured glycogen accumulates over time in Lafora disease (LD) and precipitates into Lafora bodies (LBs), leading to neurodegeneration and intractable fatal epilepsy. Constitutive reduction of glycogen synthase-1 (GYS1) activity prevents murine LD, but the effect of GYS1 reduction later in disease course …

ca, us (code pays fourni par la source)

32 citations Journal of Biological Chemistry

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.